We are live on ! Find out more
Kayne Anderson Rudnick Investment Management

Kayne Anderson Rudnick Investment Management Portfolio holdings

AUM $34B
1-Year Est. Return 6.31%
This Fund
S&P 500
This Quarter Est. Return
-10.21%
1 Year Est. Return
+6.31%
3 Year Est. Return
+45.79%
5 Year Est. Return
+60.99%
10 Year Est. Return
+604.27%
AUM
$37.6B
AUM Growth
-$5.8B
Cap. Flow
-$178M
Cap. Flow %
-0.47%
Top 10 Hldgs %
18.46%
Holding
738
New
79
Increased
223
Reduced
233
Closed
75

Top Buys

Rank Stock Value
1
WSO icon
Watsco Inc
WSO
+$199M
2
EXPO icon
Exponent
EXPO
+$135M
3
BANF icon
BancFirst
BANF
+$95.3M
4
BSY icon
Bentley Systems
BSY
+$93.9M
5
TDY icon
Teledyne Technologies
TDY
+$87.7M

Sector Composition

Rank Sector Weight
1 Industrials 26.1%
2 Technology 21.14%
3 Financials 19.52%
4 Healthcare 9.21%
5 Consumer Discretionary 8.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EPIX
626
DELISTED
ESSA Pharma
EPIX
$1K ﹤0.01%
+97
New +$853
EVGO icon
627
EVgo
EVGO
$497M
$1K ﹤0.01%
99
FATE icon
628
Fate Therapeutics
FATE
$317M
$1K ﹤0.01%
+16
New +$620
FDMT icon
629
4D Molecular Therapeutics
FDMT
$621M
$1K ﹤0.01%
+52
New +$817
GE icon
630
GE Aerospace
GE
$379B
$1K ﹤0.01%
19
-121
-86% -$7.22K
HCAT icon
631
Health Catalyst
HCAT
$135M
$1K ﹤0.01%
+32
New +$908
HERO icon
632
Global X Video Games & Esports ETF
HERO
$67.3M
$1K ﹤0.01%
50
ICUI icon
633
ICU Medical
ICUI
$4.48B
$1K ﹤0.01%
+6
New +$1.34K
JANX icon
634
Janux Therapeutics
JANX
$1.02B
$1K ﹤0.01%
+42
New +$687
LAZR
635
DELISTED
Luminar Technologies
LAZR
$1K ﹤0.01%
3
LEA icon
636
Lear
LEA
$8.07B
$1K ﹤0.01%
8
LFST icon
637
Lifestance Health
LFST
$4.67B
$1K ﹤0.01%
+87
New +$764
MRNA icon
638
Moderna
MRNA
$25.4B
$1K ﹤0.01%
6
+1
+20% +$168
OLMA icon
639
Olema Pharmaceuticals
OLMA
$913M
$1K ﹤0.01%
+128
New +$705
PHAT icon
640
Phathom Pharmaceuticals
PHAT
$742M
$1K ﹤0.01%
+39
New +$630
PRAX icon
641
Praxis Precision Medicines
PRAX
$10.8B
$1K ﹤0.01%
+5
New +$1.03K
PRVA icon
642
Privia Health
PRVA
$2.75B
$1K ﹤0.01%
+30
New +$708
PSIL icon
643
AdvisorShares Psychedelics ETF
PSIL
$52.9M
$1K ﹤0.01%
31
RYTM icon
644
Rhythm Pharmaceuticals
RYTM
$8.1B
$1K ﹤0.01%
+72
New +$632
SAGE
645
DELISTED
Sage Therapeutics
SAGE
$1K ﹤0.01%
+20
New +$752
SHC icon
646
Sotera Health
SHC
$5.39B
$1K ﹤0.01%
+38
New +$806
TNDM icon
647
Tandem Diabetes Care
TNDM
$1.63B
$1K ﹤0.01%
+7
New +$817
VNT icon
648
Vontier
VNT
$4.52B
$1K ﹤0.01%
33
VTRS icon
649
Viatris
VTRS
$18.5B
$1K ﹤0.01%
73
-1
-1% -$13
ACCD
650
DELISTED
Accolade Inc
ACCD
$1K ﹤0.01%
+37
New +$681

Similar funds

Kayne Anderson Rudnick Investment Management's Q1 2022 Portfolio in Review

As of Q1 2022, Kayne Anderson Rudnick Investment Management held 738 positions worth $37.6B, down 13% from $43.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Kayne Anderson Rudnick Investment Management's Q1 2022 filing shows 79 new, 223 increased, 233 reduced and 75 closed positions. Its largest new stake was Roblox: 615,038 shares worth $28.4M. The largest sale was MSCI, an estimated $426M.

By sector, the portfolio is most concentrated in Industrials at 26% of assets, down from 26% a quarter earlier, followed by Technology and Financials.

  • Kayne Anderson Rudnick Investment Management's largest Q1 2022 buy was Roblox: 615,038 shares worth $28.4M.
  • Kayne Anderson Rudnick Investment Management added most to Watsco Inc in Q1 2022, an estimated $199M increase.
  • Kayne Anderson Rudnick Investment Management's biggest Q1 2022 reduction was MSCI, cutting an estimated $426M.
  • Kayne Anderson Rudnick Investment Management fully exited Dynatrace in Q1 2022, selling an estimated $52M.
  • Kayne Anderson Rudnick Investment Management's ten largest holdings make up 18% of its $37.6B portfolio in Q1 2022.
  • Kayne Anderson Rudnick Investment Management opened 79 new positions and closed 75 in Q1 2022.
  • Kayne Anderson Rudnick Investment Management's portfolio value fell 13% quarter-over-quarter to $37.6B.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q1 2022, filed 16 May 2022.